News
-
Libido drug marginal
Wednesday | Mar 2 2016A NEW systematic review and meta-analysis have concluded that the benefits of Boehringer Ingelheim’s female “libido.
-
New OTC regulations
Wednesday | Mar 2 2016EFFECTIVE as of yesterday, the Therapeutic Goods Administration has announced an updated set of mandatories relating.
-
Zika recommendation
Wednesday | Mar 2 2016AMERICA’S Food and Drug Administration has issued new guidance for immediate implementation providing recommendations to reduce.
-
New scholarships
Wednesday | Mar 2 2016THE Australian and New Zealand Association for Health Processional Educators (ANZAHPE) has partnered with Australian Medicines.
-
Nurofen rebuts class action
Wednesday | Mar 2 2016NUROFEN manufacturer Reckitt Benckiser (RB) has defended its position relating to the class action by Bannister.
-
Alcidion listing
Wednesday | Mar 2 2016ELECTRONIC health software provider Alcidion has formally debuted on the share market, in a $34 million.
-
PBS website update
Tuesday | Mar 1 2016THE Pharmaceutical Benefits Scheme has updated its website to reflect changes effective from today.
-
AFT international growth
Tuesday | Mar 1 2016NEWLY listed Australasian drugmaker company AFT Pharmaceuticals yesterday announced a major licensing deal for its Maxigesic,.
-
Guild Update – 1 March 16 : Hepatitis C – New Medicines PBS Listings Information
Tuesday | Mar 1 2016GUILD Members would be aware that the Government has approved listing of the following medicines for.
-
DISPENSARY CORNER 1 March 16
Tuesday | Mar 1 2016LOVERS of coffee and alcohol rejoice – one may offset the negative affects of the other.